MenB vaccination: introduction from September 2015

This letter provides details of the new meningococcal group B (MenB) vaccine (Bexsero®) programme from 1 September 2015.


Introduction of MenB vaccination for infants

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This joint letter from Public Health England and NHS England sets out the details of the addition of the new MenB vaccine (Bexsero®) to the routine childhood immunisation schedule from 1 September 2015. This includes guidance on:

  • those infants eligible for vaccination
  • clinical advice on use of Bexsero®
  • details of how to order the vaccine
  • new data collection arrangements to measure vaccine uptake
  • funding arrangements
Published 22 June 2015